Skip to contentI
Inspire Medical Systems, Inc.
I
INSPInspire Medical Systems, Inc. Q2 2020 · 10-Q
Revenue$12.18M$12.18M−32.4% vs Q2 2019 Net Income-$23.09M-$23.09MN/M vs Q2 2019 EPS Diluted-$0.88-$0.88N/M vs Q2 2019 Gross Profit$10,229,000−31.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Inspire Medical Systems, Inc. · CIK 1609550 · Engraved from SEC EDGAR
Operating Cash Flowderived-$25,251,000N/M Free Cash Flowderived-$25,632,000N/M Margins · derivedGross margin84.0%+1.1 pt vs Q2 2019
Operating margin-187.3%−141.9 pt vs Q2 2019
Net margin-189.5%−147.1 pt vs Q2 2019
ended Jun 30, 2020 · filed Aug 4, 2020 · 35 d after period end